Logo

Caris Life Sciences: Milan Radovich

Sep 24, 2021

Caris Life Sciences said this week that Milan Radovich has joined the firm as chief precision medicine officer. In this role, Radovich will lead Caris' biomarker and drug intelligence teams, aiming to develop novel signatures and drug targets. Before joining Caris, Radovich was an associate professor at the Indiana University School of Medicine, vice president for oncology genomics at Indiana University Health, and co-director of the IU Health Precision Genomics Program. As a National Cancer Institute-funded investigator, his research focused on the use of genomics in translational oncology, particularly on the use of genomics in clinical studies, genomically informed drug combinations, circulating biomarkers for cancer detection, and creating novel bioinformatic pipelines for cancer genome analyses.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.